Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Samuel A L, Hall"'
Autor:
Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone I Strasser, William Sievert, Paul V Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, Kathy Jackson, Margaret Littlejohn, Scott Bowden, Stephen A Locarnini, Alexander J Thompson, Kumar Visvanathan
Publikováno v:
The Journal of Infectious Diseases. 227:123-132
Background We evaluated the patterns of peripheral Toll-like receptor (TLR) signaling activity and the expression of TLRs and natural killer (NK) cell activation in a cohort of patients experiencing severe hepatitis flares after stopping nucleot(s)id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96195df56d6d5554c2616e986f479876
https://doi.org/10.1093/infdis/jiac375
https://doi.org/10.1093/infdis/jiac375
Autor:
Samuel A. L. Hall, Gareth S. Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John S. Lubel, Amanda J. Nicoll, Simone I. Strasser, William Sievert, Paul V. Desmond, Meng C. Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Kathy Jackson, Margaret Littlejohn, D. Scott Bowden, Stephen A. Locarnini, Kumar Visvanathan, Alexander J. Thompson
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:310-320
Current guidelines recommend long-term nucleot(s)ide analogue (NA) therapy for patients with HBeAg-negative chronic hepatitis B (CHB). However, disease remission has been described after stopping NA therapy, as well as HBsAg loss.We performed a prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e154ed04ea7a9c079c4e6fce8a8e39a
https://doi.org/10.1111/apt.16968
https://doi.org/10.1111/apt.16968
Autor:
Chris Karapetis, Samuel A. L. Hall, Kate Muller, Douglas Coghlan, Mohammad A. Chinnaratha, Mahsa Tantiongco, Richard J. Woodman, Abdul Shaikh, Kailin Teh, Alan Wigg
Publikováno v:
Internal Medicine Journal. 48:936-943
Background International guidelines recommend screening for hepatitis B virus (HBV) infection prior to administration of rituximab, due to high risk of HBV reactivation in at-risk patients. Aims To determine: (i) adherence to the South Australian (SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7bc4efa84a821d07eae4b68a40d5222
https://doi.org/10.1111/imj.13740
https://doi.org/10.1111/imj.13740
Autor:
Samuel A L, Hall, Abdul, Shaikh, Kailin, Teh, Mahsa, Tantiongco, Douglas, Coghlan, Chris S, Karapetis, Mohammad A, Chinnaratha, Richard, Woodman, Kate R, Muller, Alan J, Wigg
Publikováno v:
Internal medicine journal. 48(8)
International guidelines recommend screening for hepatitis B virus (HBV) infection prior to administration of rituximab, due to high risk of HBV reactivation in at-risk patients.To determine: (i) adherence to the South Australian (SA) protocol for HB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff01511b7638e6e8d4f9c036da87f291
https://pubmed.ncbi.nlm.nih.gov/29345413
https://pubmed.ncbi.nlm.nih.gov/29345413